156 related articles for article (PubMed ID: 12192603)
1. Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma.
Gharib TG; Chen G; Wang H; Huang CC; Prescott MS; Shedden K; Misek DE; Thomas DG; Giordano TJ; Taylor JM; Kardia S; Yee J; Orringer MB; Hanash S; Beer DG
Neoplasia; 2002; 4(5):440-8. PubMed ID: 12192603
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors.
Chen G; Gharib TG; Huang CC; Thomas DG; Shedden KA; Taylor JM; Kardia SL; Misek DE; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
Clin Cancer Res; 2002 Jul; 8(7):2298-305. PubMed ID: 12114434
[TBL] [Abstract][Full Text] [Related]
3. Discordant protein and mRNA expression in lung adenocarcinomas.
Chen G; Gharib TG; Huang CC; Taylor JM; Misek DE; Kardia SL; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
Mol Cell Proteomics; 2002 Apr; 1(4):304-13. PubMed ID: 12096112
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of eIF-5A in lung adenocarcinomas.
Chen G; Gharib TG; Thomas DG; Huang CC; Misek DE; Kuick RD; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
Proteomics; 2003 Apr; 3(4):496-504. PubMed ID: 12687616
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new membrane-associated proteins overexpressed in small-cell lung cancer.
Ocak S; Friedman DB; Chen H; Ausborn JA; Hassanein M; Detry B; Weynand B; Aboubakar F; Pilette C; Sibille Y; Massion PP
J Thorac Oncol; 2014 Mar; 9(3):324-36. PubMed ID: 24518087
[TBL] [Abstract][Full Text] [Related]
6. Genomic and proteomic analyses of vascular endothelial growth factor and insulin-like growth factor-binding protein 3 in lung adenocarcinomas.
Gharib TG; Chen G; Huang CC; Misek DE; Iannettoni MD; Hanash SM; Orringer MB; Beer DG
Clin Lung Cancer; 2004 Mar; 5(5):307-12. PubMed ID: 15086970
[TBL] [Abstract][Full Text] [Related]
7. Protein profiles associated with survival in lung adenocarcinoma.
Chen G; Gharib TG; Wang H; Huang CC; Kuick R; Thomas DG; Shedden KA; Misek DE; Taylor JM; Giordano TJ; Kardia SL; Iannettoni MD; Yee J; Hogg PJ; Orringer MB; Hanash SM; Beer DG
Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13537-42. PubMed ID: 14573703
[TBL] [Abstract][Full Text] [Related]
8. A database of protein expression in lung cancer.
Oh JM; Brichory F; Puravs E; Kuick R; Wood C; Rouillard JM; Tra J; Kardia S; Beer D; Hanash S
Proteomics; 2001 Oct; 1(10):1303-19. PubMed ID: 11721642
[TBL] [Abstract][Full Text] [Related]
9. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
[TBL] [Abstract][Full Text] [Related]
10. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
[TBL] [Abstract][Full Text] [Related]
11. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets.
Tan J; Sidhu G; Greco MA; Ballard H; Wieczorek R
Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790
[TBL] [Abstract][Full Text] [Related]
12. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade.
Jerome Marson V; Mazieres J; Groussard O; Garcia O; Berjaud J; Dahan M; Carles P; Daste G
Histopathology; 2004 Aug; 45(2):125-34. PubMed ID: 15279630
[TBL] [Abstract][Full Text] [Related]
13. Identification of proteins expressed differently among surgically resected stage I lung adenocarcinomas.
Ha ES; Choi S; In KH; Lee SH; Lee EJ; Lee SY; Kim JH; Shin C; Shim JJ; Kang KH; Phark S; Sul D
Clin Biochem; 2013 Mar; 46(4-5):369-77. PubMed ID: 23200884
[TBL] [Abstract][Full Text] [Related]
14. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment.
Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Yan W; Liang Z; Xiong H; Chen K
Tumour Biol; 2015 Sep; 36(10):8085-92. PubMed ID: 25982999
[TBL] [Abstract][Full Text] [Related]
15. The prognostic application of cytokeratin typing of nonsmall cell lung carcinoma. A retrospective study.
Cohen R; Guber A; Siegal A; Bruderman I; Huszar M; Yellin A; Marom Z; Geiger B
Cancer; 1997 Feb; 79(3):468-73. PubMed ID: 9028356
[TBL] [Abstract][Full Text] [Related]
16. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas.
Chen G; Wang H; Miller CT; Thomas DG; Gharib TG; Misek DE; Giordano TJ; Orringer MB; Hanash SM; Beer DG
J Pathol; 2004 Mar; 202(3):321-9. PubMed ID: 14991897
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of oncoprotein 18 correlates with poor differentiation in lung adenocarcinomas.
Chen G; Wang H; Gharib TG; Huang CC; Thomas DG; Shedden KA; Kuick R; Taylor JM; Kardia SL; Misek DE; Giordano TJ; Iannettoni MD; Orringer MB; Hanash SM; Beer DG
Mol Cell Proteomics; 2003 Feb; 2(2):107-16. PubMed ID: 12644570
[TBL] [Abstract][Full Text] [Related]
18. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis.
Ding SJ; Li Y; Tan YX; Jiang MR; Tian B; Liu YK; Shao XX; Ye SL; Wu JR; Zeng R; Wang HY; Tang ZY; Xia QC
Mol Cell Proteomics; 2004 Jan; 3(1):73-81. PubMed ID: 14593079
[TBL] [Abstract][Full Text] [Related]
19. Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma.
Lappi-Blanco E; Mäkinen JM; Lehtonen S; Karvonen H; Sormunen R; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Kaarteenaho R
Tumour Biol; 2016 Oct; 37(10):13811-13820. PubMed ID: 27481516
[TBL] [Abstract][Full Text] [Related]
20. RANTES expression is a predictor of survival in stage I lung adenocarcinoma.
Moran CJ; Arenberg DA; Huang CC; Giordano TJ; Thomas DG; Misek DE; Chen G; Iannettoni MD; Orringer MB; Hanash S; Beer DG
Clin Cancer Res; 2002 Dec; 8(12):3803-12. PubMed ID: 12473593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
